News & Events
Press Releases
On the 28th March 2022, OncoArendi changed its name to Molecure
Galapagos informed about the initiation of a clinical trial to evaluate potential pharmacokinetic interactions of GLPG4716
21 July 2021
OncoArendi executes the strategy for 2021-2025 in the area of R&D platform for developing small molecules modulating RNA function
16 June 2021
OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis
5 November 2020
American Journal of Medicinal Chemistry distinguishes OncoArendi publication on OATD-01
21 October 2020
OncoArendi Therapeutics expands the therapeutic potential of its Chitinase Platform
13 October 2020
OncoArendi Therapeutics broadens its collaboration with VIB, a leading life science research institute in Europe, to investigate the role of chitinase family of proteins as potential therapeutic targets in COVID-19 patients
11 September 2020
Events & Presentations
EFMC – International Symposium on Medicinal Chemistry – Ljubljana 02-06.09.2018
17 September 2018
54th International Conference on Medicinal Chemistry, Strasbourg, France – July 4-6, 2018.
17 July 2018
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, October 26 – 30, 2017
1 October 2017